Search research articles
Contact Us
Filters
Showing results (41-50 of 57) with videos related to
Page
of 6
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
September 21, 2012
Adjunctive β2-agonists reverse neuromuscular involvement in murine Pompe disease
Songtao Li, Baodong Sun, Mats I Nilsson, et al.
Molecular Therapy. Methods & Clinical Development
|
September 11, 2025
High-potency MyoAAV capsids enhanced skeletal muscle correction in a mouse model of GSD IIIa
Kuo-An Liao, Sang-Oh Han, Mercedes Barzi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 9, 2004
Efficacy of an adeno-associated virus 8-pseudotyped vector in glycogen storage disease type II
Baodong Sun, Haoyue Zhang, Luis M Franco, et al.
Human Gene Therapy
|
January 21, 2012
Immunodominant liver-specific expression suppresses transgene-directed immune responses in murine pompe disease
Ping Zhang, Baodong Sun, Takuya Osada, et al.
Comparative Medicine
|
February 18, 2016
Natural Progression of Canine Glycogen Storage Disease Type IIIa
Elizabeth D Brooks, Haiqing Yi, Stephanie L Austin, et al.
Molecular Genetics and Metabolism
|
March 15, 2011
Enhanced efficacy of enzyme replacement therapy in Pompe disease through mannose-6-phosphate receptor expression in skeletal muscle
Dwight D Koeberl, Xiaoyan Luo, Baodong Sun, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 22, 2006
Enhanced efficacy of an AAV vector encoding chimeric, highly secreted acid alpha-glucosidase in glycogen storage disease type II
Baodong Sun, Haoyue Zhang, Daniel K Benjamin, et al.
Molecular Genetics and Metabolism
|
January 16, 2013
Alglucosidase alfa enzyme replacement therapy as a therapeutic approach for glycogen storage disease type III
Baodong Sun, Keri Fredrickson, Stephanie Austin, et al.
Molecules (Basel, Switzerland)
|
September 15, 2020
Transcriptomic and Proteomic Analysis of Clear Cell Foci (CCF) in the Human Non-Cirrhotic Liver Identifies Several Differentially Expressed Genes and Proteins with Functions in Cancer Cell Biology and Glycogen Metabolism
Christoph Metzendorf, Katharina Wineberger, Jenny Rausch, et al.
Molecular Genetics and Metabolism
|
June 4, 2021
Characterization of liver GSD IX γ2 pathophysiology in a novel Phkg2<sup>-/-</sup> mouse model
Rebecca A Gibson, Jeong-A Lim, Su Jin Choi, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 57) with videos related to
Sort By:
Page
of 6
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
September 21, 2012
Adjunctive β2-agonists reverse neuromuscular involvement in murine Pompe disease
Songtao Li, Baodong Sun, Mats I Nilsson, et al.
Molecular Therapy. Methods & Clinical Development
|
September 11, 2025
High-potency MyoAAV capsids enhanced skeletal muscle correction in a mouse model of GSD IIIa
Kuo-An Liao, Sang-Oh Han, Mercedes Barzi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 9, 2004
Efficacy of an adeno-associated virus 8-pseudotyped vector in glycogen storage disease type II
Baodong Sun, Haoyue Zhang, Luis M Franco, et al.
Human Gene Therapy
|
January 21, 2012
Immunodominant liver-specific expression suppresses transgene-directed immune responses in murine pompe disease
Ping Zhang, Baodong Sun, Takuya Osada, et al.
Comparative Medicine
|
February 18, 2016
Natural Progression of Canine Glycogen Storage Disease Type IIIa
Elizabeth D Brooks, Haiqing Yi, Stephanie L Austin, et al.
Molecular Genetics and Metabolism
|
March 15, 2011
Enhanced efficacy of enzyme replacement therapy in Pompe disease through mannose-6-phosphate receptor expression in skeletal muscle
Dwight D Koeberl, Xiaoyan Luo, Baodong Sun, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 22, 2006
Enhanced efficacy of an AAV vector encoding chimeric, highly secreted acid alpha-glucosidase in glycogen storage disease type II
Baodong Sun, Haoyue Zhang, Daniel K Benjamin, et al.
Molecular Genetics and Metabolism
|
January 16, 2013
Alglucosidase alfa enzyme replacement therapy as a therapeutic approach for glycogen storage disease type III
Baodong Sun, Keri Fredrickson, Stephanie Austin, et al.
Molecules (Basel, Switzerland)
|
September 15, 2020
Transcriptomic and Proteomic Analysis of Clear Cell Foci (CCF) in the Human Non-Cirrhotic Liver Identifies Several Differentially Expressed Genes and Proteins with Functions in Cancer Cell Biology and Glycogen Metabolism
Christoph Metzendorf, Katharina Wineberger, Jenny Rausch, et al.
Molecular Genetics and Metabolism
|
June 4, 2021
Characterization of liver GSD IX γ2 pathophysiology in a novel Phkg2<sup>-/-</sup> mouse model
Rebecca A Gibson, Jeong-A Lim, Su Jin Choi, et al.
Page
of 6